NICE backs ‘artifical pancreas’ tech for type 1 diabetics

An independent NICE committee has recommended that thousands of people with type 1 diabetes who can’t control the condition with current glucose monitoring and insulin pump devices should be offered new hybrid closed-loop (HCL) systems.